Apollo Green today announced it has added New Zealand medicinal cannabis genetics to its library.

“We’re delighted to add Rua Biosciences unique East Coast cannabis strains to our library”, said Oisin Tierney, Director of Strategic Partnerships. “At Apollo Green our mission is to build the world’s leading cannabis genetics. This a goal to which we have always remained focussed. Our library now includes the leading genetic strains from New Zealand.”

“Apollo Green now holds one of the world’s largest libraries of medicinal cannabis phenotypes – 900+ varieties.”

“We’re equally pleased to be partnering with an Indigenous Enterprise, “ he said. “Canada has a long and deeply rich indigenous history. Apollo Green has sought to proactively foster this heritage and now we can do so in New Zealand too.”

“We are excited about this partnership with Apollo Green as it aligns perfectly with our vision to take our unique strains to the world” said Paul Naske, CEO of Rua Bioscience. “This is more than just an agreement; it’s a bridge connecting New Zealand’s exceptional cannabis genetics and indigenous heritage to the world.”

“This agreement not only highlights Rua Bioscience’s commitment to innovation and quality but also underscores the potential of New Zealand’s cannabis industry on the world stage,” he said.
“The cannabis industry is rapidly growing globally, and has been for a number of years now, “ said Tom Varga, Biortica’s CEO.

“We welcome Rua to the Apollo Green and Biortica Agrimed family, “said Tom Varga, CEO of Biortica Agrimed. “Biortica Agrimed is a leader in commercial scale B2B medicinal cannabis cultivation and is Australia’s largest, and fastest growing, producer of medicinal cannabis. We’re delighted to make a positive contribution in growing the broader cannabis family right across the globe.”